Deep Track Capital’s Strategic Investment in Reneo Pharmaceuticals
Overview of the Recent Transaction
On October 4, 2024, Deep Track Capital, LP (Trades, Portfolio) marked a significant portfolio addition by acquiring 68,415.6 shares of Reneo Pharmaceuticals Inc (NASDAQ:RPHM). This transaction, categorized as a new holding, was executed at a price of $18.20 per share. The acquisition not only diversifies Deep Track Capitals investment portfolio but also underscores its strategic interest in the biotechnology sector, particularly in companies involved in rare genetic mitochondrial diseases.
Insight into Deep Track Capital, LP (Trades, Portfolio)
Deep Track Capital, LP (Trades, Portfolio), headquartered at 200 Greenwich Avenue, Greenwich, CT, is a prominent investment firm managing an equity portfolio worth…
